Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
Fibroblast growth factor 23 (FGF23), a hormone secreted by osteocytes and osteoblasts, is a major regulator of vitamin D and phosphate homeostasis. FGF23 has been associated with the disturbance of mineral homeostasis, and with kidney and cardiovascular diseases. Systemic lupus erythematosus (SLE) i...
Main Authors: | Yolanda Fernández-Cladera, Fuensanta Gómez-Bernal, María García-González, Juan C. Quevedo-Abeledo, Agustín F. González-Rivero, Antonia de Vera-González, Candelaria Martín-González, Ana L. Nunes-Andrade, Raquel López-Mejías, Miguel Á. González-Gay, Iván Ferraz-Amaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/8/1222 |
Similar Items
-
Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
by: Fuensanta Gómez-Bernal, et al.
Published: (2023-04-01) -
Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
by: Fuensanta Gómez-Bernal, et al.
Published: (2022-12-01) -
Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
by: Fuensanta Gómez-Bernal, et al.
Published: (2022-12-01) -
Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
by: Nayra Merino de Paz, et al.
Published: (2023-07-01) -
Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus
by: Yolanda Fernández-Cladera, et al.
Published: (2024-03-01)